126 related articles for article (PubMed ID: 38670245)
1. Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy.
Lu W; Cheng S; Xu J; Xiao Z; Yu Y; Xie Q; Fang Y; Chen R; Shen B; Xie Y; Ding X
Toxicol Lett; 2024 May; 396():81-93. PubMed ID: 38670245
[TBL] [Abstract][Full Text] [Related]
2. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
[TBL] [Abstract][Full Text] [Related]
3. Benzo(a)pyrene induces MUC5AC expression through the AhR/mitochondrial ROS/ERK pathway in airway epithelial cells.
Sun Y; Shi Z; Lin Y; Zhang M; Liu J; Zhu L; Chen Q; Bi J; Li S; Ni Z; Wang X
Ecotoxicol Environ Saf; 2021 Mar; 210():111857. PubMed ID: 33421718
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin.
Zhang Y; Wang S; Huang Y; Yang K; Liu Y; Bi X; Liu C; Xiong J; Zhang B; Zhao J; Nie L
Mol Med Rep; 2020 Jan; 21(1):393-404. PubMed ID: 31746392
[TBL] [Abstract][Full Text] [Related]
6. Indoxyl glucuronide, a protein-bound uremic toxin, inhibits hypoxia-inducible factor‒dependent erythropoietin expression through activation of aryl hydrocarbon receptor.
Asai H; Hirata J; Watanabe-Akanuma M
Biochem Biophys Res Commun; 2018 Oct; 504(2):538-544. PubMed ID: 30205954
[TBL] [Abstract][Full Text] [Related]
7. Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK/UCP2 signaling pathway.
Yang K; Xu X; Nie L; Xiao T; Guan X; He T; Yu Y; Liu L; Huang Y; Zhang J; Zhao J
Toxicol Lett; 2015 Apr; 234(2):110-9. PubMed ID: 25703824
[TBL] [Abstract][Full Text] [Related]
8. Aryl Hydrocarbon Receptor Activation and Tissue Factor Induction by Fluid Shear Stress and Indoxyl Sulfate in Endothelial Cells.
Lano G; Laforêt M; Von Kotze C; Perrin J; Addi T; Brunet P; Poitevin S; Burtey S; Dou L
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244284
[TBL] [Abstract][Full Text] [Related]
9. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
[TBL] [Abstract][Full Text] [Related]
10. Crucial Role of the Aryl Hydrocarbon Receptor (AhR) in Indoxyl Sulfate-Induced Vascular Inflammation.
Ito S; Osaka M; Edamatsu T; Itoh Y; Yoshida M
J Atheroscler Thromb; 2016 Aug; 23(8):960-75. PubMed ID: 26860885
[TBL] [Abstract][Full Text] [Related]
11. Indoxyl sulfate upregulates the cannabinoid type 1 receptor gene via an ATF3/c-Jun complex-mediated signaling pathway in the model of uremic cardiomyopathy.
Hsu YJ; Hsu SC; Chang YL; Huang SM; Shih CC; Tsai CS; Lin CY
Int J Cardiol; 2018 Feb; 252():128-135. PubMed ID: 29203210
[TBL] [Abstract][Full Text] [Related]
12. A tryptophan-derived uremic metabolite/Ahr/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease.
Thome T; Vugman NA; Stone LE; Wimberly K; Scali ST; Ryan TE
JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38652558
[TBL] [Abstract][Full Text] [Related]
13. Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis.
Shyu JF; Liu WC; Zheng CM; Fang TC; Hou YC; Chang CT; Liao TY; Chen YC; Lu KC
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681927
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells.
Addi T; Poitevin S; McKay N; El Mecherfi KE; Kheroua O; Jourde-Chiche N; de Macedo A; Gondouin B; Cerini C; Brunet P; Dignat-George F; Burtey S; Dou L
Arch Toxicol; 2019 Jan; 93(1):121-136. PubMed ID: 30324315
[TBL] [Abstract][Full Text] [Related]
15. Indoxyl sulfate downregulates expression of Mas receptor via OAT3/AhR/Stat3 pathway in proximal tubular cells.
Ng HY; Yisireyili M; Saito S; Lee CT; Adelibieke Y; Nishijima F; Niwa T
PLoS One; 2014; 9(3):e91517. PubMed ID: 24614509
[TBL] [Abstract][Full Text] [Related]
16. Uremic toxin indoxyl 3-sulfate regulates the differentiation of Th2 but not of Th1 cells to lessen allergic asthma.
Hwang YJ; Yun MO; Jeong KT; Park JH
Toxicol Lett; 2014 Feb; 225(1):130-8. PubMed ID: 24291743
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial activity and oxidative stress functions are influenced by the activation of AhR-induced CYP1A1 overexpression in cardiomyocytes.
Zhou B; Wang X; Li F; Wang Y; Yang L; Zhen X; Tan W
Mol Med Rep; 2017 Jul; 16(1):174-180. PubMed ID: 28498411
[TBL] [Abstract][Full Text] [Related]
18. Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings.
Nguyen C; Edgley AJ; Kelly DJ; Kompa AR
Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202128
[TBL] [Abstract][Full Text] [Related]
19. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
[TBL] [Abstract][Full Text] [Related]
20. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway.
Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S
Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
